ArticlePDF Available

Neuroprotective and memory improvement effects of a standardized extract of Emilia coccinea (SIMS) G. on animal models of anxiety and depression

Authors:

Abstract and Figures

The present study evaluated the putative effects of the methanolic extract of Emilia coccinea leaves (MEC) on the central nervous system, including anxiety, depression-like behavior, and memory, in Wistar rats. The behavioral assays included open-field, elevated plus maze, forced swimming and Ymaze. The antioxidant activity of the extract was also measured in vitro. MEC showed a significant antioxidant activity. It significantly increased the number of open arm entries and time spent in the open arms of the elevated plus maze test. The rearing time as well as the time spent at the centre of the open field was significantly increased. MEC also significantly decreased the number of lines crossed and the climbing time on this task. In the forced swimming test, the extract was as effective as Imipramine in inducing shortening of immobility time while after 3 days of treatment, it significantly improves spatial memory in the Y-maze task.
Content may be subject to copyright.
~ 146 ~
Journal of Pharmacognosy and Phytochemistry 2014; 3(3): 146-154
E-ISSN: 2278-4136
P-ISSN: 2349-8196
JPP 2014; 3(3): 146-154
Received: 23-08-2014
Accepted: 16-09-2014
Foyet Harquin Simplice
Department of Biological Sciences,
Faculty of Science, University of
Maroua, Cameroon. P.O. Box: 814,
Maroua, Cameroon.
Abdou, Bouba Armand
Department of Agriculture, Animal
husbandry and Derived products,
High Institute of the Sahel,
University of Maroua, Cameroon.
P.O. Box: 46, Maroua.
Ngatanko Abaissou Hervé Her
Department of Life and Earth
Sciences, Higher Teachers’ Training
College, University of Maroua,
Cameroon. P.O. Box: 55, Maroua.
Manyi Forka Lucy
Department of Life and Earth
Sciences, Higher Teachers’ Training
College, University of Maroua, P.O.
Box: 55, Maroua, Cameroon.
Manyo Nkongho Annabel
Department of Life and Earth
Sciences, Higher Teachers’ Training
College, University of Maroua,
Cameroon.
Shu Nyenti Patence Neh
Department of Life and Earth
Sciences, Higher Teachers’ Training
College, University of Maroua,
Cameroon.
Asongalem Emmanuel Acha
Department on Biomedical Sciences,
Faculty of Health Sciences,
University of Buea, Cameroon.
Correspondence:
Foyet Harquin Simplice
Department of Biological Sciences,
Faculty of Science, University of
Maroua, Cameroon. P.O. Box: 814,
Maroua, Cameroon.
Neuroprotective and memory improvement effects of a
standardized extract of Emilia coccinea (SIMS) G. on
animal models of anxiety and depression
Foyet Harquin Simplice, Abdou, Bouba Armand, Ngatanko Abaissou
Hervé Hervé, Manyi Forka Lucy, Manyo Nkongho Annabel, Shu Nyenti
Patence Neh, Asongalem Emmanuel Acha
Abstract
The present study evaluated the putative effects of the methanolic extract of Emilia coccinea leaves
(MEC) on the central nervous system, including anxiety, depression-like behavior, and memory, in
Wistar rats. The behavioral assays included open-field, elevated plus maze, forced swimming and Y-
maze. The antioxidant activity of the extract was also measured in vitro. MEC showed a significant
antioxidant activity. It significantly increased the number of open arm entries and time spent in the open
arms of the elevated plus maze test. The rearing time as well as the time spent at the centre of the open
field was significantly increased. MEC also significantly decreased the number of lines crossed and the
climbing time on this task. In the forced swimming test, the extract was as effective as Imipramine in
inducing shortening of immobility time while after 3 days of treatment, it significantly improves spatial
memory in the Y-maze task.
Keywords: Emilia coccinea, Antioxidant, flavonoids, Anxiety, Depression, spatial memory
1. Introduction
Emilia coccinea (SIMS) G. (Asteraccae) is an annual herb commonly found throughout the
plain of the Central Africa and in dry areas up to 2000 m altitude in the eastern Africa. This
species belongs to the genus Emilia represented by about 100 species, with 50 of them found
in Africa [1]. In traditional medicine, this plant is used for the treatment of fever, convulsions
and epilepsy in children [2]. The sap is also applied to ulcers body rashes and abscesses. The
dry leaves are used for the treatment of wounds, sores and sinusitis ulcer, ringworm [3], but
also to treat jaundice, abdominal pains, and gastritis. In some tribe in the western part of
Cameroon, the infusion of the dry leaves of this plant is used as a potent sedative and
restorative. Previous phytochemical studies on E. coccinea have reported the presence of
alkaloids, tannin, saponin, steroid, terpenoid, flavonoid and cardiac glycoside [4-5]. Quantitative
estimation of the percentage of crude chemical constituents in the Nigerian E. coccinea was
0.92±0.22% of alkaloids, 0.81±0.10% of phenols, 0.96±0.10% of flavonoid, 2.30±0.20 of
saponin and 11.85±0.31 of tannin [4].
According to the WHO report, approximately 450 million people suffer from a mental or
behavioural disorder. This accounted for 12.3% of the global burden of disease, and this
percentage may rise up to 15% by 2020 from predictions. The brain is susceptible to free-
radical damage due to its comparatively high levels of oxygen metabolism and also relatively
deficient in both free-radical scavenging enzymes and antioxidant molecules as compared to
other organs. Oxidative stress by the imbalance between free radicals and the antioxidant
system is a prominent and early feature in the pathogenesis of neuronal damage [6].
Different therapeutic regimens are employed to treat anxiety and depressive disorders; but
their clinical uses are limited by their side effects such as psychomotor impairment,
potentiation of other central depressant drugs and dependence liability. In the search for new
therapeutic products for the treatment of neurological disorders, research on medicinal plant
has also contributed significantly by demonstrating pharmacological effectiveness of different
herbs in various animal models.
Various activities of the entire herb, including antibacterial, antioxidant and anti-inflammatory
~ 147 ~
Journal of Pharmacognosy and Phytochemistry
activities have been reported in various studies [7], but no
scientific data are available for the central nervous systems
actions of the leaves of E. coccinea although this plant is
used for the treatment of some neurological disorders in the
western part of the Cameroon. The presence of flavonoids
and phenolic compounds in the leaves of E. coccinea
suggests that this plant possesses antioxidant properties and
can have neuroprotective propensity. Therefore, the aim of
this study was to examine the antidepressant-like, anxiolytic-
like and sedative actions of the methanol extract of the
methanolic extract of Emilia coccinea using animal models.
Putative anxiolytic-like and antidepressant-like properties of
E. coccinea were studied in the elevated plus-maze, open
field and forced swimming test, while the effect on short
term memory was investigated in Y-maze.
2. Methods
2.1. Plant material and extraction
Fresh leaves of E. coccinea were harvested in September
2013 at Etoug Ebe in the Centre Region of Cameroon and
authenticated at the National Herbarium-Yaoundé, where the
voucher specimen was conserved under the reference number
6297/HNC. The leaves were then washed and dried at room
temperature (24-26 °C during 10 days).
Methanolic extract was prepared as follows: after drying
fresh leaves and powdering it, 500 g of the powder were
mixed with 500 ml of the solvent at room temperature and
agitated for eight hours in a flask shaker using a magnetic
agitator. The mixture was then filtered thought a Whatman
paper. This was followed by the elimination of the solvent by
a rotavapor. The given powder yielded 8.80% of a brown
extract. The same process was done for the fresh leaves.
2.2. Experimental animals
Male Wistar albino rats (weighing 100-180 g) were obtained
from the Laboratory of Biophysics and Biochemistry of the
Department of Food Sciences and Nutrition, University of
Ngaoundéré, Cameroon. The animals were housed in
polyacrylic cages (6 animals / cage) and maintained at a
temperature and light-controlled room (25 ± 2 °C, a 12-h
cycle). The animals were acclimatized to laboratory
conditions for 7 days before the start of experiment. Prior to
and after treatment, the animals were fasted for 12 and 7 h,
respectively. However, all animals were allowed to drink
water ad libitum. Rats were treated in accordance with the
guidelines of the Cameroonian Bioethics Committee (reg
N°.FWA-IRB00001954) and in accordance with NIH- Care
and Use of Laboratory Animals manual ( 8th Edition).
2.3. Chemicals
Diazepam hydrochloride and Imipramine were purchased
from Novartis Turkey and used as reference drugs. All drugs
and extracts were freshly prepared in saline on the day of the
experiments and administered intraperitoneally (i.p.). Control
animals received 10 ml/kg body of the vehicle in the same
route of administration.
2.4. In vitro analysis
2.4.1. Determination of mineral composition
Micro and macro-elements were determined by dry ashing in
muffle furnace 500 °C. 1 g of ground sample in a porcelain
crucible was ashed in conventional resistance muffle furnace
(CMF). The ash was diluted in 5ml of diluted mixture of
HCl/HNO3 acids, following by 20 mL of hot water and
brought to 100 mL in deionised water. Ca, Mg, Na, K, Zn,
Cu, Mn, and Fe were analyzed using Atomic Absorption
Spectrometer. Phosphorous (P) was also determined as above
but analyzed using Murphy Riley reagent and read
colorimetrically [8].
2.4.2. Determination of total phenolic content
Total phenol content was determined spectrophotometrically
in the extracts by using Folin–Ciocalteu method. 0.04 mL
(0.0125 M) of the methanolic extract of E. coccinea was
added to 1.36 mL distilled water and 0.2 mL of freshly
prepared Folin–Ciocalteu reagent, followed by incubation in
the darkness for 5 min. Then, 0.4 mL of 20% sodium
carbonate solution was added. The test tubes were stirred
with the help of a vortex and the samples were incubated at
40 °C in the darkness for 30 min. The UV–vis spectra of all
the samples were recorded against the reference solution
(zero gallic acid) and the absorbance was read at 760 nm.
The measurements were done four times. For the gallic acid
standard, a calibration curve (Pearson’s correlation
coefficient: R2 = 0.999) was constructed and the total level of
phenolics for each sample was determined in terms of gallic
acid equivalents [9].
2.4.3. Determination of anti-oxidant activity
Two model systems: 2, 4-dinitrophenyl-1-picryl hydrazyl
(DPPH) radical scavenging activity and ferric Iron reduced
activity assay were used to measure the antioxidant activities
of the extract. In the two in vitro tests, ascorbic acid and
quercetin were used as standard antioxidant compounds
respectively.
2.4.3.1. Ferric reducing antioxidant power (FRAP) assay
The antioxidant capacity of the methanolic extract of E.
coccinea leaves were evaluated by determining its ability to
reduce iron (Fe3+) into Fe2+ using Oyaizu method [10]. The
methanolic extract of E. coccinea leaves (0.1 mL) were
mixed with 2.5 ml of phosphate buffer (0.2 M, pH 6.6) and
2.5 ml of potassium hexacyanoferrate solution (K3Fe(CN)6)
at 1%. The mixture was incubated at 50 °C for 30 min. 2.5
mL of trichloroacetic acid (10%) was added and the mixture
centrifuged for 10 min. 0.5 mL was pipetted into a test tube
and mixed with 2.5 mL of distilled water and 0.5 ml of
aqueous solution of FeCl3 (0.1%). The absorbance was read
at 700 nm in a spectrophotometer. Ascorbic acid was used as
reference and the total reducing power (Ferric Iron reducing
activity) was expressed as ascorbic acid equivalent.
2.4.3.2. Free radical scavenging activity (DPPH assay
method)
The free radical scavenging activity of the methanolic extract
of E. coccinea was evaluated as described by Zhang and
Hamauzu [11]. Briefly, 2 mL of DPPH (0.1 mM prepared in
methanol) was introduced in each test tube containing 0.25
µL of the fresh extract. The mixture was stirred for 5 min and
incubated in darkness for 60 min at room temperature. For
the control tube, methanol was used in the place of the
extract while quercetin was used as reference at variable
concentration. A curve was drawn from this reference and
the absorbance read at 517 nm. Each assay was repeated four
times and the results, recorded as mean of the fourth
experiments.
~ 148 ~
Journal of Pharmacognosy and Phytochemistry
The antioxidant activity of the extract was expressed as
grams of quercetin equivalent/100g of the extract. The
inhibition percentage was calculated from the following
equation.
PI (%) = [(DO control-DOessay) x100]/DOcontrol
2.5. Behavioral evaluation
2.5.1. Open Field Activity test (OFT)
The open field apparatus was constructed of white polywood
and measured 72 x 72 cm with 36 cm walls. Red lines were
drawn on the floor with a marker and were clearly visible
through the clear Plexiglas floor. Rats were treated (i.p) with
single administration of the methanolic extract of E. coccinea
leaves and the test were performed 30 min after the drug
administration of the extract (200 and 400 mg/kg, i.p.) or
saline (10 ml/kg). The standard drug diazepam (1 mg/kg, i.p.)
was given once 30 min before the test. The rats were placed
in the open field box for 5 min, and their behaviors were
recorded. The behaviors scored included: time spent at the
center square, number of the lines crossed on the floor of the
maze, time spent at the border of the maze, grooming
(duration of time the animal spent licking or scratching itself
while stationary), and the climbing time [12].
2.5.2. Elevated plus-maze test (EPM)
Behavior in the elevated plus-maze (EPM) is used to assess
exploratory, anxiolytic and motor activity. The possible
anxiolytic effects of the methanolic extract of E. coccinea
leaves were assessed, basically using the same method
described by Casarrubea et al. [13]. The EPM consists of four
arms, 49 cm long and 10 cm wide, arranged in such a way
that the two arms of each type were opposite to each other.
The maze was elevated 50 cm above the floor. Two arms
were enclosed by walls 30 cm high and the other two arms
were exposed. Rats were treated i.p. with single
administration of the methanolic extract of E. coccinea
leaves (200 and 400 mg/kg; i.p) or saline (10 ml/kg; i.p). The
positive control diazepam (1 mg/kg, i.p) was given once 30
min before the test. Thirty minutes after the i.p. injection of
the extract or saline, each animal was placed at the center of
the maze facing one of the enclosed arms. During a 5 min
test period, the number of open and enclosed arm entries, as
well as the time spent in open and enclosed arms, were
recorded as previously described [14]. Entry into an arm was
defined as the point when the animal places all four paws
into the arm. After the test, the maze was carefully cleaned
with wet cotton (70% ethanol solution) and allowed to dry
before the next animal.
2.5.3. Forced swimming test (FST)
The FST is the most widely used pharmacological models for
assessing antidepressant activity [15]. The development of
immobility when the rodents are placed in an inescapable
cylinder of water reflects the cessation of persistent escape-
directed behavior [16]. The possible antidepressant effects of
the methanolic extract of E. coccinea leaves were assessed,
basically using the same method described by Kawaura et al.
[17] with minor modifications. Rats were treated with single
administration of the methanolic extract of E. coccinea
leaves (200 and 400 mg/kg; i.p) or saline (10 ml/kg; i.p). The
standard drug imipramine (10 mg/kg, i.p) was given once 30
min before the test. On the first day of the experiments
(pretest session), rats were individually placed into
transparent Plexiglas cylinder (50 cm high and 20 cm wide)
filled to a 30 cm depth with water at 26 ± 1 ºC. The animals
were left to swim for 15 min before being removed, dried
and returned to their cages.
The procedure was repeated 24 h later, in a 6 min swim
session (test session) 30 min after the last dose of the
methanolic extract of E. coccinea leaves, imipramine or
saline. During the test session, the following behavioral
responses were recorded: immobility time (time spent
floating with the minimal movements to keep the head above
the water) and swimming time (time spent with active
swimming movements). Increases in active responses, such
as climbing or swimming and reduction in immobility, was
reconsidered as behavioral profiles consistent with an
antidepressant-like action [15].
3. Y-Maze test
Y-maze analysis has been shown to be a reliable,
noninvasive test to determine cognitive changes in wistar rat
through the measurement of the spontaneous alternation
behavior in the Y-maze task. The maze used in the present
study consisted of three arms (35 cm long, 25 cm high and 10
cm wide) and an equilateral triangular central area. All
animals were tested in a randomized order at the beginning
and at the end of the experimental protocol. Rats were treated
once daily with the methanolic extract of E. coccinea leaves
(200 and 400 mg/kg; i.p), diazepam (2 mg/kg, i.p.),
Diazepam (2 mg/kg, i.p.) plus E. coccinea (400 mg/kg; i.p)
or saline (10 ml/kg; i.p) during 3 consecutive days. 30 min
after the last administration of the methanolic extract of E.
coccinea leaves, diazepam or saline solution, rats were
placed at the end of one arm and allowed to move freely
through the maze for 8 min. The time limit in Y-maze test
was 8 min, and every session was stopped after 8 min. An
arm entry was counted when the hind paws of the rat were
completely within the arm. Spontaneous alternation behavior
was defined as three consecutive entries in three different
arms (i.e. A, B, C or B, C, A, etc). The percentage
alternation score was calculated using the following formula:
Total alternation number/ (Total number of entries 2) x
100. Furthermore, total number of arm entries was used as a
measure of general activity in the animals. The maze was
wiped clean with 70% ethanol between each animal to
minimize odour cues [18-19].
3.1 Statistical analysis
Data were presented as mean ± SEM values. One-way
ANOVA followed by Tukey multicomparaison “t”-test was
performed using Graph Pad Prism version 5.00 for Windows,
Graph Pad Software, San Diego California USA,
www.graphpad.com. A probability level of 0.05 or less was
accepted as significant. Pearson’s correlation coefficient and
regression analysis were used to evaluate the connection
between the working memory errors and some parameters
like locomotion, grooming and rearing in the Y-maze test.
4. Results
4.1. Total phenolic content and in vitro antioxidant
activity of Emilia coccinea
The results of the phenolic content showed that the dry
leaves of this plant contained 863.04±5.42 mg of GAE/100 g
of dry material. This represents a very good content of total
~ 149 ~
Journal of Pharmacognosy and Phytochemistry
phenolics compounds in the dry leaves and is four fold the
total phenolic content of the fresh leaves. The effect of
antioxidants on DPPH radical scavenging was thought to be
due to their hydrogen-donating ability. The preparations were
able to reduce the stable free radical DPPH to the yellow-
coloured 1,1-diphenyl-2-picrylhydrazyl, with 19.08±0.62 g
of quercetin equivalent/100 g of dry material, indicating a
weak activity against this radical. The total reducing power
was about 4.71±0.04 g of Vit C equivalent/100 g of dry
material (Table 1).
Mn and Zn were found to be very high (549.83±0.60 and
46.87±0.01 mg/100 g respectively) in our samples of E.
coccinea than those reported on other plants [20] (Table 2)
Table 1: Total phenolic content and in vitro antioxidant activity of Emilia coccinea
Test
Unit
Dry
Emilia coccinea
Emilia coccinea
Water content
g/100
g
4.41± 0.03
a
86.05±0.53
b
Total phenolic content
Mg of GAE/100
g of DM
863.04
±5.42
b
204.15
±2.04
a
Total reducing powder
g of Vit C equivalent/100
g of DM
4.71
±0.0
4
b
3.24
±0.39
a
Antiradical activity (DPPH)
g of
quercetin
equivalent/100
g of DM
19.08
±0.62
b
6.40
±0.06
a
Results present as the mean ± S.E.M. of 4 experiments. Values with different letters within a line are significantly different at 0.05 level.
Table 2: Mineral composition of Emilia coccinea leaves
Elements
Mg
(g/100 g)
Mn
(mg/100 g)
Ca
(mg/100 g)
Fe
(mg/100 g )
Zn
(mg/100 g )
Cu
(mg/100 g )
E.C
0.52
±0.003
549.83
±0.60
3.26
±0.01
265.35
±0.52
46.87
±0.01
10.23
±
0.003
Results present as the mean ± S.E.M. of 4 experiments. Samples expressed in mg/100g dry weight basis (N=4).
4.2. Effects of the methanolic extract of E. coccinea leaves
in the open field test in rats
The results given in table 3 indicate that the diazepam (2.0
mg/kg) treated rats showed a significant decrease in number
of lines crossed, climbing and rearing as well as the time
spent at the border of the field. The time spent at the centre
of the field was increased significantly at the same time.
MEC treated rats (200 mg/kg) exhibited a significant
increase in the time spent at the centre of the maze while the
extract was a sedative in all of the applied doses with
decreased in the number of line crossed. The animals were
most immobile and inactive at the dose 400 mg/kg. The
number of lines crossed by the negative control group was
greater than that of the extract-treated groups, but, the
number of lines crossed by extract-treated groups was not
significantly different to that of the diazepam-treated group,
as shown in table 4.
4.3. Effects of the extract in the EPM
In the EPM, the MEC (200, 400 mg/kg, i.p.) was found to
significantly (P < 0.05) decrease the number of entries and
the time spent by the rats in the closed arms compared to the
control animals (Fig. 1 and 2). With the diazepam (2 mg/kg),
the standard drug used in this test, the number of closed arm
entries as well as the time spent in the closed arms was
significantly decreased (P < 0.05). By considering the total
number of entries in both the arms (enclosed and open arms),
as an index of locomotory activity of the animals, the
difference between the total number of lines crossed by the
saline treated animals (33±0.96) was not significantly
different from those of MEC treated animals at the doses of
200 and 400 mg/kg (25±1.30 and 28±0.84 respectively), (F
(2.86) = 0.70, P 0.05). This difference was also
nonsignificant when compared to the diazepam -treated
animals (24±1.20) (Data not shown).
Table 3: Effects of the MEC and diazepam in the open field test in rats.
Groups Dose
(mg/kg) Number of line
crossed Climbing time
(s) Rearing Time
(s) Time spent at
the center (s) Time spent at the
border (s)
Control
-
33±3.2
19.4 ±3.12
78.8±16.56
3.80±0.96
268.00±23.60
MEC
200
8.2±2.24***
5.80±2.56***
47.20±11.76
21.20±6.76*
2
67.00±23.20
MEC
400
5.8±1.76***
3.00±1.20***
24.00±9.60**
12.80±3.04
241.00±16.00
Diazepam 2 5.4±4.32*** 2.00±1.20*** 1.20±0.32*** 114.00±12.00**
#
£
166.0±44.00****
#
£
Animals were treated with single dose of the extract (200 or 400 mg/kg, i.p.) or distilled water. In the positive control, diazepam
was given only once (2 mg/kg, i.p.) 30 min prior to the test. Results present as the mean ± S.E.M. of 6 animals. Data analysis
was performed using One way ANOVA followed by Tukey multicomparaison “t” –test. *** P < 0.0001 vs. saline-treated
animals; £ P < 0.0001 vs. 200 mg/kg; # P < 0.0001 vs. group 400 mg/kg.
~ 150 ~
Journal of Pharmacognosy and Phytochemistry
Fig 1: Effect of the methanolic extract of E. coccinea leaves on the
number of entries in open and closed arm in elevated maze test.
Experiments were performed 30 min after the administration of the
extract or diazepam (Diaz). Each column represents mean ± S.E.M.
of 6 animals. Data analysis was performed using One way ANOVA
followed by Tukey multicomparaison “t” –test. * P < 0.05 vs.
saline-treated animals; ** P < 0.01 vs. saline-treated animals.
Fig 2: Effect of the methanolic extract of E. coccinea leaves on the
time spent in open arm and closed arm in elevated maze test.
Experiments were performed 30 min after the administration of the
extract of E. coccinea or diazepam (Diaz). Each column represents
mean ± S.E.M. of 6 animals. Data analysis was performed using
One way ANOVA followed by Tukey multicomparaison “t” –test.
* P < 0.05 vs. saline-treated animals.
4.4. Effects of the extract in the FST
The figure 3 shows the effect of MEC for the duration of
immobility time in the FST model. One-way ANOVA
revealed that there were no significant differences between E.
coccinea -treatment groups (F (39.41) = 3.09, P ˃ 0.05).
Post-hoc analysis showed that the MEC (200 and 400 mg/kg)
and imipramine treated groups were significantly different
(P < 0.0001) from the vehicle treated group. MEC
significantly increased in the dose dependent manner the
duration of swimming time, indicating the antidepressant
effect of the extract. This antidepressant effect of the MEC at
the dose of 100 mg/kg was comparable to that of imipramine
(2 mg/kg).
Fig 3: Effect of the methanolic extract of E. coccinea leaves on the
immobility and swimming time in forced swimming test.
Experiments were performed 30 min after the administration of the
extract or imipramine (Imip). Each column represents mean ±
S.E.M. of 6 animals. Data analysis was performed using One way
ANOVA followed by Tukey multicomparaison “t” –test. ** P <
0.001; *** P < 0.0001 vs. saline-treated animals.
4.5. Effects of the extract in the Y-Maze task
In Y-maze task, we observed after three days administration
a significant increase of spatial memory in animal treated
with high-dose (400 mg/kg) of the methanolic extract of E.
coccinea leaves (F (3.68) = 6.47, P < 0.01) (Fig. 4a),
indicated by an increase of spontaneous alternation
percentage compared to control group, suggesting effects on
short term-memory. At the same time, the plant extract (200,
400 mg/kg) and diazepam (2 mg/kg), significantly, and at a
dose -dependent manner, decreased the total number of
arm entries of the animals when compared to control group
(F (3.09) = 8.69, p ˂0.0007) (Figure 4b). More importantly,
when linear regression was determined, no significant
positive correlation between spontaneous alternation vs.
number of entries in the maze (n=7, r2=0. 237, p=0.2678)
(Figure 5) was noted. It can also be clearly realized that
Diazepam, GABAA agonist slightly impaired short term
memory of rats, although this was not significant compared
to control animals.
~ 151 ~
Journal of Pharmacognosy and Phytochemistry
Fig 4: Effect of the methanolic extract of E. coccinea leaves and diazepam (Diaz) on the spontaneous alternation percentage (A) and number of
entries (B) in Y-maze task. Experiments were performed 30 min after 3 days administration of the extract. Each column represents mean ±
S.E.M. of 7 animals. Data analysis was performed using One way ANOVA followed by Tukey multicomparaison “t” –test. * P < 0.05; ** P <
0.001; ** P < 0.0001 vs. control animals; £ P < 0.001 vs. 400 mg/kg treated animals.
Fig 5: Correlation between working memory errors vs. locomotor activities and rearing behavior of rats treated with the MEC at
the dose of 400 mg/kg.
5. Discussion
The present study provides behavioral evidence for the
anxiolytic and antidepressant-like activities of E. coccinea.
The EPM and OF test are regularly used to study anxiolytic
effects of plant extract while the forced swimming tests are
widely accepted behavioral models for the assessment of
antidepressant activity. E. coccinea has been used to treat
some neurological-related diseases in traditional medicine
such as convulsion and epilepsy, but its specific
neuropharmacological activities have not yet been
demonstrated. The findings of the current investigation show
for the first time that MEC, standardized in its content of
flavonoids with doses of quercetin (19.08 g /100 g of DM),
Vit C (4.71 08 g /100 g of DM), Gallic acid (863.04 mg /100
g of DM), Mn and Zn (549.83±0.60 and 46.87±0.01 mg/100
g of DM respectively) possesses a significant anxiolytic and
antidepressant properties.
The open field test is a paradigm used for evaluating the
effect of drugs on gross general behavior and is used to
measure the level of nervous excitability [21-22]. When
removed from their acclimatized home cages and placed in a
novel environment, animals express their anxiety and fear by
showing decreased ambulation and exploration,
immobilization or freezing, and modification in normal
rearing and grooming behavior. Increased micturation and
defecation due to augmented autonomic activity is also
observed. These paradigms are attenuated by classical
anxiolytics and potentiated by anxiogenic agents [23]. In the
open field behavioral task, the MEC was seen to increase
time spent at the center of the maze and decrease peripheral
square movements; the observed decrease in central square
movements could be due to the impairment of locomotory
~ 152 ~
Journal of Pharmacognosy and Phytochemistry
activity. The decrease in locomotory (number of lines
crossed and rearing) activity in the open field test of rats
treated with the extract produces more evidence for its
central nervous depressant activity. The decrease in the
rearing activity (vertical movement), as well as grooming, an
emotional activity parameter, was also significantly affected
by treatment with the MEC. Diazepam used as a positive
control drug, also significantly reduced anxiety state in the
open-field test with some depressive side effects.
A behavioral assay extensively used for the studies of acute
behavioral stress reactivity is the elevated plus maze (EPM).
When animals were taken from their home cage and given
access to either an open maze alley or a closed maze alley,
they spent more time exploring the closed arms as a
characteristic of an approach-avoidance conflict [24]. The
EPM test has several characteristics that make it particularly
useful. It reliably detects anxiolytic and anxiogenic activity
of a variety of therapeutic and experimental drugs of
different classes. Unlike models that require extensive
conditioning, it relies on an innate conflict between
competing “drives”, the balance of which is affected by the
level of anxiety. Thus, it requires no training, deprivation,
pain or aversive stimuli. The response involves the
redirection of an ongoing activity (i.e., exploration) rather
than the suppression of behavior, which could be confounded
by sedation or ataxia. Several plants increase the exploration
of open arms in the elevated plus-maze test and are used to
diminish anxiety in folk medicine. Among them are Trichilia
catigua and Plumeria rubra [25-26].
Conventional anxiety indices in the elevated plus-maze test
comprise percent open arm entries and percent time spent in
these areas in the maze, with anxiolytics generally increasing
and anxiogenics decreasing these measures. In this regard, in
the elevated plus-maze test, the MEC (200 and 400 mg/kg,
i.p.) increased the exploration and the time spent in the open
arms in a non-dose-related way. The number of entries and
the time spent in the enclosed arms were also significantly
reduced when compared to the control group: indicating that
the MEC has an anxiolytic-like effect. As expected,
diazepam reduced the animal's natural aversion to the open
arms and promoted maze exploration. Literature reports
describe the action of benzodiazepines, such as diazepam, as
anxiolytics when used at the lowest doses, but these effects
are associated with the sedation and myorelaxant effects at
higher doses. Our results clearly indicated that the dose of
diazepam used in this study also act as sedative.
In the forced swimming test, the animals are forced to swim
in a very restricted space from which there is no way to
escape. They rapidly develop a state of despair behavior
characterized by a low motivation for escaping as shown by
the increased periods of immobility. In this experiment, the
immobility displayed by rodents when subjected to
unavoidable stress such as forced swimming is thought to
reflect a state of despair or lowered mood, which is thought
to reflect depressive disorders in humans. This behavioral
test is sensitive to serotoninergic compounds, such as the
selective serotonin reuptake inhibitor fluoxetine [12]. The
immobility time has also been shown to be reduced by
treatment with tricyclic antidepressant drugs like imipramine,
which typically increase the swimming efforts of the animal
seeking a solution to the problem and, therefore, they
decrease the duration of immobility in the forced swimming
test [27]. In this study, the single administration of the MEC
provoked significant reduction of the immobility time of rats
subjected to forced swimming when compare to the control
group. This result shows that the extract possesses
antidepressant activity on the central nervous system. It is
noteworthy that in the FST test, false positive results can be
obtained from agents that stimulate locomotory activity [28].
In the open field test, we clearly showed that the MEC
significantly reduced the locomotory activity of the animals
(number of lines crossed and rearing), this confirms the
assumption that the antidepressant-like effect of the extract in
the FST is specific [29].
Working memory allows animals to remember information
that is useful for a single session of an experiment but not for
subsequent sessions and spontaneous alternation behavior is
considered to reflect spatial working memory, which is a
form of short-term memory. The Y-maze task is a specific
and sensitive test of spatial recognition memory in rodents.
The test relies on an innate tendency of rats to explore a
novel environment [30]. The Y-maze used in this study
involves no aversive stimuli and was considered suitable for
evaluating memory and the specific part of the brain involved
in performance of this task include the hippocampus [31-33].
As shown in our results, the MEC at the dose of 100 mg/kg
did not significantly increase the number of spontaneous
alternation. However rats treated with high dose of the
methanolic extract of E. coccinea (400 mg/kg) showed a
significant improvement in spatial learning with an increase
number of spontaneous alternations and reduction of a
percentage of bias, when compared to control. This result
suggests that the plant extract (400 mg/kg) displays
improvement effect on acquisition of the short term-memory
of the rats within Y-maze task. This effect is however linked
to a marked significant decrease in exploratory behavior,
probably due to the myorelaxant effect of the extract. At this
level of our study it is not possible to suggest any possible
mechanism of action of the extract since the process for the
acquisition of short-term memory is a very complex
biological process. At the same time the implication of the
GABAA agonist in the impairment of the learning and
memory in the spontaneous alternation paradigm is clearly
evident. However, the results obtained from the linear
regression results suggest that the improvement of the
acquisition of the short term memory could not be related to
the locomotory activities of the animals treated with the
MEC. In our experiment, the rats receiving both the MEC
and diazepam did no show any sign of memory impairment.
This result suggested that the extract may counteract the
effects of diazepam, as a GABA antagonist and in that case
its anxiolytic effect will be through serotoninergic pathway.
This result may also indicate that the MEC does not act
through the GABA receptors, during the short term memory
process but through other receptors types like glutaminergic,
cholinergic or dopaminergic receptors. The implication of
these receptors in the process of learning and memory is
known well established [34].
Extracts of many plant species that contain a number of
polyphenolic compounds have been shown to present
antioxidant properties. The antioxidant activity of
polyphenolics has been attributed to their redox properties,
which allow them to act as reducing agents or hydrogen-atom
donors [35]. In the present study, a higher antioxidant activity
was observed with the MEC. A very high content of total
phenolics has been determined in the E. coccinea leaves
~ 153 ~
Journal of Pharmacognosy and Phytochemistry
(863.04±5.42 mg of GAE/100 g of dry material, 19.08±0.62
g of quercetin equivalent/100 g of dry material), we cannot
exclude that the scavenging activity could result from their
presence, namely, on the basis of a synergistic effect with
other metabolites [36].
The presence of Cu, Zn and Mn ions in our sample, which
are metallic co-factor of anti-oxidant enzyme, give credence
on the anti-oxidant properties of E. coccinea. In this way,
antioxidant properties have been related to some of
pharmacological effects of secondary metabolites of the
plant. Weinreb et al. [37] showed that the neuroprotective
activities of the green tea are based on the antioxidant
activities of epicatechins. Thus, it is possible that both
functional and antioxidant activities of the MEC observed in
the present work are related.
In conclusion, the present study clearly demonstrated that the
methanolic extract of E. coccinea leaves treatment could
significantly prevent anxiety and depression state. The
positive effect of the treatment on memory suggests the
therapeutic potential of this extract in aging and age-related
neurodegenerative disorders where cognitive impairment is
involved. However, for other behavioral effects of MEC and
underling mechanism(s) of action, further preclinical
investigations are necessary.
6. Competing interest
The authors declare that they have no competing interests.
7. Authors' contributions
FHS, MFL, MNA and SNPN carried out the study; ABA,
and FHS, designed the experiments. FHS and NAHH wrote
the manuscript; FHS and ABA supervised the work. All
authors read and approved the final manuscript.
8. Acknowledgments
Foyet Harquin Simplice was supported by TWAS grant N°:
12-132 RG/BIO/AF/AC_G.
9. References
1. Bosch CH. Emilia coccinea (Sims) G.Don In: Grubben,
G.J.H. & Denton, O.A. (Editors). PROTA 2,
Vegetables/Légumes. PROTA, Wageningen,
Netherlands, 2004.
2. Agoha RC. Medicinal plants of Nigeria. Offsetdikker
Jifaculteit waskunden, Natnurwenten schopp; pen,
Netherlands, 1981; 22-158.
3. Burkill HM. The useful plants of West Tropical Africa
Vol 3, Families J-L. Royal Botanical Garden kew, 1984,
522.
4. Edeoga HO, Okwu DE, Mbaebie BO. Phytochemical
constituents of some nigerian medicinal plants. African
Journal of Biotechnology 2005; 4(7):685-688.
5. Teke GN, Kuiate JR, Ngouateu OB, Gatsing D.
Antidiarrhoeal and antimicrobial activities of Emilia
coccinea(Sims) G. Don extracts. Journal of
Ethnopharmacology 2007; 112:278-283
6. Uttara B, Singh VA, Zamboni P, Mahajan RT. Oxidative
Stress and Neurodegenerative Diseases: A Review of
Upstream and Downstream Antioxidant Therapeutic
Options. Current Neuropharmacology 2009; 7(1):65-74.
7. Okiei W, Ogunlesi M, Ademoye MA. An assessment of
the antimicrobial properties of extracts of various
polarities from Chasmanthera dependens, Emilia
coccinea and Cuscuta australis, herbal medications for
eye diseases. Journal of Applied Sciences 2009; 9:4076-
4080.
8. Murphy J, Riley JP. A modified single solution method
for the determination of phosphate in natural waters.
Analytica Chimica Acta 1962; 27:31-36.
9. Gao X, Bjo kL, Trajkovski V, Uggla M. Evaluation of
antioxidant activities of rosehip ethanol extracts in
different test systems. Journal of Agricultural and Food
Chemistry 2000; 80:2021-2027.
10. Oyaizu M. Studies on products of browning reactions:
antioxidative activities of products of browning reaction
prepared from glucosamine. Japanese Journal of
Nutrition 1986; 44:307-315.
11. Zhang D, Hamauzu Y. Phenolics, ascorbic acid,
carotenoids and antioxidant activity of broccoli and their
changes during conventional and microwave cooking.
Food Chemistry 2004; 88:503-509.
12. Foyet HS, Tsala ED, Bouba AA, Hritcu L. Anxiolytic
and antidepressant-like effects of the aqueous extract of
Alafia multiflora stem barks in rodents. Hindawi
Publishing Corporation. Advances in Pharmacological
Sciences, 2012.
13. Casarrubea M, Roy V, Sorbera F, Magnussonb MS,
Santangelo A, Arabo A et al. Significant divergences
between the temporal structure of the behavior in Wistar
and in the spontaneously more anxious DA/Han strain of
rats tested in elevated plus maze. Behavioral brain
research 2013; 250:166-173.
14. Adeyemi OO, Akindele AJ, Yemitan OK, Aigbe FR,
Fagbo FI. Anticonvulsant, anxiolytic and sedative
activities of the aqueous root extract of Securidaca
longepedunculata Fresen. Journal of
Ethnopharmacology 2010; 130(2):191-195.
15. Cryan JF, Markou A, Lucki I. Assessing antidepressant
activity in rodents: recent developments and future need.
Trends in Pharmacological Sciences 2002; 23(5):238-
245.
16. Ulak G, Mutlu O, Yıldız Akar F, Komsuoğlu FI, Tanyeri
P, Erden BF et al. Neuronal NOS inhibitor 1-(2-
trifluoromethylphenyl)-imidazole augment the effects of
antidepressants acting via serotonergic system in the
forced swimming test in rats. Pharmacology
Biochemistry and Behavior 2008; 90(4):563-8.
17. Kawaura K, Miki R, Urashima Y, Kawahara R, Soeda F,
Shirasaki T, Takahama K et al. Pharmacological
mechanisms of antidepressant-like effect of tipepidine in
the forced swimming test. Behavioral Brain Research
2012; 226:381-385.
18. Siedlak SL, Casadesus G, Webber KM, Pappolla MA,
Atwood CS, Smith MA et al. Chronic antioxidant
therapy reduces oxidative stress in a mouse model of
Alzheimer’s disease. Free Radical Research 2009;
43(2):156-164.
19. Hernández-Chan NG, Góngora-Alfaro JL, Álvarez-
Cervera FJ, Solís-Rodríguez FA, Heredia-López FJ,
Arankowsky-Sandoval G et al. Quinolinic acid lesions
of the pedunculopontine nucleus impair sleep
architecture, but not locomotion, exploration,
emotionality or working memory in the rat. Behavioral
Brain Research 2011; 225:482- 490.
20. Bouba AA, Njintang YN, Foyet HS, Scher J, Mbufong
CMF. Proximate composition, minerals and vitamins
~ 154 ~
Journal of Pharmacognosy and Phytochemistry
contents of some wild plants used as spaces in
Cameroun. Food Nutrition Sciences 2012; 3:423-432.
21. File SE, Fernandes C. Dizocilpine prevents the
development of tolerance to the sedative effects of
diazepam in rats. Pharmacology Biochemistry and
Behavior 1994; 47:823-6.
22. Hines TJ, Minton BR. Effects of environmental
enrichment on rat behavior in the open field test.
Proceedings of the National Conference on
undergraduate research (NCUR) 2012 Weber State
University, Ogden, 2012, 29-31.
23. Varsha J, Bharatkumar GP. Effect of hydroalcoholic
extract of Sphaeranthus indicus against experimentally
induced anxiety, depression and convulsions in rodents.
International Journal of Ayurveda Research 2010;
1(2):87-92.
24. Lapiz-Bluhm MD, Bondi CO, Doyen J, Rodriguez GA,
Bédard-Arana T, Orilak DS et al. Behavioral assays to
model cognitive and affective dimensions of depression
and anxiety in rats. Journal of Neuroendocrinology
2008; 20:1115-1137.
25. Chassot JM, Longhini R, Gazarini L, Mello JCP,
Weffort-de Oliveira RM. Preclinical evaluation of
Trichilia catigua extracts on the central nervous system
of mice. Journal of Ethnopharmacology 2011; 137:1143
-1148.
26. Chatterjee M, Verma R, Lakshmi V, Sengupta S, Verma
AK, Mahdi AA et al. Anxiolytic effects of Plumeria
rubra var. acutifolia (Poiret) L. flower extracts in the
elevated plus-maze model of anxiety in mice. Asian
Journal of Psychiatry 2013; 6(2):13-118.
27. Herrera-Ruiz M, Zamilpa A, Gonzalez-Cortazar M,
Reyes-Chilpa R, Leon E, Garcia MP, Tortoriello J,
Huerta-Reyes M. Antidepressant effect and
pharmacological evaluation of standardized extract of
flavonoids from Byrsonima crassifolia. Phytomedicine
2011, 18:1255-1261.
28. Bourin M, Fiocco AJ, Clenet F. How valuable are animal
models in defining antidepressant activity? Hum.
Psychopharmacology 2001; 16:9-21
29. Sanchez-Mateo CC, Bonkanka CX, Prado B, Rabanal
RM. Antidepressant properties of some Hypericum
canariense L and Hypericum glandulosum Ait extracts
in the forced swimming test in mice. Journal of
Ethnopharmacology 2005; 97:541-547.
30. Yusuf S, Adelaiye BA, Agunu A. Effect of Ziziphus
mauritiania (L.) seed extracts on spatial recognition
memory of rats as measured by the Y-maze test. Journal
of Natural Products 2009; 2:31-39.
31. Borght KVD, Havekes R, Bos T, Eggen BJL, Zee
EAVD. Exercise improves memory acquisition and
retrieval in theY-Maze Task: Relationship with
hippocampal neurogenesis. Behavioral Neurosciences
2007; 121(2):324-334.
32. Bagheri M, Joghataei MT, Mohseni S, Roghani M.
Genistein ameliorates learning and memory deficits in
amyloid β(1–40) rat model of Alzheimer’ s disease.
Neurobiology Learning and Memory 2011; 95:270-276.
33. Liu DS, Zhou YH, Liang ES, Li W, Lin WW, Chen FF
et al. Neuroprotective effects of the Chinese Yi-Qi-Bu-
Shen recipe extract on injury of rat hippocampal neurons
induced by hypoxia/reoxygenation. Journal of
Ethnopharmacology 2013; 145:168-174.
34. Myhrer T. Neurotransmitter systems involved in
learning and memory in the rat: a meta-analysis based on
studies of four behavioral tasks. Brain Research Reviews
2003; 41:268-287.
35. Zhang G, Hu M, He L, Fu P, Wang L, Zhou J et al.
Optimization of microwave-assisted enzymatic
extraction of polyphenols from waste peanut shells and
evaluation of its antioxidant and antibacterial activities
in vitro. Food and Bioproducts Processing 2013;
91(2):158-168.
36. Saito M, Sakagami H, Fujisawa S. Cytotoxicity and
apoptosis induction by butylated hydroxyl anisole
(BHA) and buty lated hydroxytoluene (BHT).
Anticancer Research 2003; 23:4693-4701.
37. Weinreb O, Mandel S, Bar-Am O, Yogev-Falach M,
Avramovich-Tirosh Y, Mit T et al. Multifunctional
neuroprotective derivatives of rasagiline as anti-
alzheimer's disease drugs. Neurotherapy 2009; 6:163-
174.
... erefore, developing novel antipsychotic drugs with better safety and efficacy is crucial. In this field, some studies have focused on seeking new natural compounds from medicinal plants with promising value in the treatment of neuropsychiatric disorders [31][32][33], but studies assessing bacterial metabolites for their therapeutic effects as neuropsychiatric behaviors modulating agents remain relatively limited [34][35][36]. ...
... e decrease in mice's exploratory and locomotor activities could be explained either by a potential myorelaxant effect of these extracts when administered at higher doses or by an impairment of the exploratory and/or locomotor behaviors in the corresponding treated mice. In this context, Foyet and his group [33] were interested in testing the effect of Emilia coccinea on the improvement of short-term memory in a dose-dependent manner. ey noticed a significant augmentation of spatial memory in animals treated with a high dose of Emilia coccinea extract (400 mg/kg), which was reflected in an increased percentage of spontaneous alternations. ...
... However, the number of arm entries was decreased compared to that of mice receiving a less concentrated dose (200 mg/kg) of the same extract, suggesting sedative effect of the tested extract when administered at high doses. Even more, Foyet and his group compared the extract behavior to that of diazepam (a known anxiolytic and antidepressant medication that acts as a sedative at high doses) and found that mice exhibited the same behavior [33]. Elevated plus maze is used to evaluate anxiety-like behavior by considering time spent in open arms as a main index of anxiety as suggested by Ciobica et al. [52]. ...
Article
Full-text available
Recently, the implication of oxidative stress in behavioral-like disorders has received a lot of attention. Many studies were interested in searching for new natural compounds with protective effects on behavioral-like disorders by focusing on oxidative stress as the main causal factor. Here, we assess the potential effect of cell-free extracts from halophilic bacteria on memory, anxiety, and depression-related behaviors in mice, as well as on cognitive deficits, negative symptoms, and some oxidative stress biomarkers in methionine-induced mice models of schizophrenia. Firstly, crude extracts of bacteria isolated from the Dead Sea were screened for their effects on memory and anxiety- and depression-like behaviors through Y-maze, elevated plus maze, and forced swimming test, respectively, using two doses 60 mg/kg and 120 mg/kg. Then, 120 mg/kg of two bacterial crude extracts, from two strains designated SL22 and BM20 and identified as Bacillus stratosphericus and Pseudomonas zhaodongensis, respectively, with significant contents of phenolic and flavonoid-like compounds, were selected for the assessment of cognitive and negative symptom improvement, as well as for their effects on oxidative stress status in methionine-induced mice models of schizophrenia using six groups (controls, methionine, crude extracts solely, and combinations of crude extracts and methionine). Results showed that the administration of the crude extracts caused a significant increase in the spontaneous alternations in the Y-maze task, the time spent in open arms of the elevated plus maze, and a decrease in immobility time in the forced swimming test in comparison with the control group. Furthermore, the administration of bacterial extracts seemed to diminish disorders related to cognitive and negative symptoms of schizophrenia and to improve the oxidative state in the temporal lobes, in comparison with the methionine group. Our findings suggest substantial antioxidant and anti-neuropsychiatric effects of the crude extracts prepared from Pseudomonas zhaodongensis strain BM20 and Bacillus stratosphericus strain SL22 and that further studies are needed to purify and to determine the active fraction from the extracts. 1. Introduction During the last decade, a great attention was given to the role of oxidative stress in neuropsychiatric disorders. Many studies have recently demonstrated that the overproduction of free radicals is involved in several behavioral disorders such as short-term memory impairment, anxiety, depression, and schizophrenia [1–4]. In normal aerobic conditions, reactive oxygen species (ROS) are produced as intermediates during metabolic reactions, and then oxidative stress takes place in the presence of altered redox control, resulting in excessive production of ROS usually along with aberrant antioxidant defense mechanisms [5], which might damage the cells by affecting the functional maintenance of major biomolecules (DNA, proteins, and lipids) and gene expression [6, 7]. Moreover, ROS may attack phospholipids and polyunsaturated fatty acids (PUFA) leading to unstable membrane structure and impaired signal transduction and producing severe pathological and toxic species such as malondialdehyde (MDA), a biomarker of lipid peroxidation in living systems [3, 4]. To protect the living systems from ROS damage and toxicity, various enzymatic and nonenzymatic antioxidant pathways are involved to keep their production under tight control [8]. The protective enzymatic pathways act in a cooperative cascade that includes, among others, superoxide dismutase (SOD) and glutathione peroxidase (GPx) [3, 9] in order to reduce the damaging effect of ROS throughout different processes including prevention of ROS formation, scavenging free radicals, preventing the radical chain reaction of oxidation, and/or retarding the lipid peroxidation process [10]. Schizophrenia is a common psychotic disorder characterized by gross distortion from reality [8] and associated with several substantial psychiatric comorbid disorders [11], the most common being depression and anxiety disorders, which contribute to high rate of morbidity and mortality among patients with schizophrenia [12]. Depressive symptoms could be observed in all stages of schizophrenia [13], with a prevalence rate of 55% in the first episode psychosis [14]. On the other hand, anxiety has been considered as a score aspect of schizophrenia, namely, panic and social anxiety symptoms [15]. Prevalence rates are reported between 35 and 65% in patients with schizophrenia [16]. Otherwise, rates of anxiety and depression diagnostic comorbidity vary across the process of schizophrenia [17]. Considering the complex pathophysiology of schizophrenia, different hypotheses have been proposed regarding the etiology, pathophysiology, and routes of treatment of these disorders [18–20]. Currently, evidence sustains that cellular damage of key macromolecules induced by increased oxidative stress levels could play a critical role in schizophrenia. The failure of the antioxidant defense system in protecting against ROS formation damages cell membranes, impacts neurotransmission, and eventually leads to phenotypes of schizophrenia [21]. For deeper studies, symptoms of schizophrenia are generally induced in animal models via overadministration of methionine for 7 and 15 days [22]. Hence, it was reported that methionine is able to replicate both positive and negative symptoms, as well as cognitive deficits of schizophrenia [19, 22, 23]. It is worth recalling that methionine (Met) is an essential amino acid required for S-adenosyl methionine (SAM) generation and in almost all methylation reactions of a very wide range of substrates including proteins, phospholipids, RNA, and DNA [24]. In turn, SAM is a major methyl donor that influences the central nervous system (CNS) function through several methylation reactions, the most relevant being deactivation via methylation of multiple neurotransmitters, epigenesis through methylation of key molecules involved in gene expression (DNA, RNA, and histones), and methylation of phospholipids [25]. In addition, methionine is considered as an intermediate substrate for the synthesis of some amino acids such as homocysteine, a nonessential amino acid that is involved in oxidative stress and cognitive dysfunctions [26], formed via demethylation of L-methionine [27]. Recent studies have shown that chronic administration of methionine induces hyperhomocysteinemia and contributes to subsequent cognitive function deterioration, which could be attributed to increased levels of oxidative stress and lipid peroxidation by hyperhomocysteinemia [28, 29]. It is well known that cellular hyperhomocysteinemia causes autooxidation of thiol groups that generate hydrogen peroxide and other ROS leading to oxidative stress [30]. Overall, Met is considered as a main factor in the etiology of schizophrenia [22]. Treatment of schizophrenic symptoms is mainly based on approved antipsychotic drugs. However, long-term use of antipsychotics has limited efficacy and has been associated with various side effects such as weight gain, metabolic disturbances, oxidative stress, sudden cardiac death, and cognitive impairment, which highly limit their clinical use [20]. Therefore, developing novel antipsychotic drugs with better safety and efficacy is crucial. In this field, some studies have focused on seeking new natural compounds from medicinal plants with promising value in the treatment of neuropsychiatric disorders [31–33], but studies assessing bacterial metabolites for their therapeutic effects as neuropsychiatric behaviors modulating agents remain relatively limited [34–36]. Halophilic bacteria are defined as microorganisms with high ability to live in very saline biotopes [37] and have been widely reported for their capacity of producing promising biocompounds with a large spectrum of activities [38, 39] including antioxidant, anticancer, and immunomodulatory activities [39–41]. Nonetheless, to our knowledge, no data have been reported on the effects of halophilic bacteria on schizophrenic-like symptoms. Considering the pharmaceutical importance of metabolites produced by halophilic bacteria in harsh conditions and their powerful antioxidant activity and in view of the little data reported on the effects of these halophilic bacterial extracts on neuropsychiatric disorders [42], the present study aims at isolating halophilic bacteria producing metabolites that could potentially act on short-term memory impairment, anxiety, depression-like behaviors, and schizophrenia-like disorders in animal models. Some oxidative stress biomarkers were also considered. 2. Materials and Methods 2.1. Bacteria Isolation Littoral soil and water samples were collected from Dead Sea (Jordan) at the following global positioning system coordinates: 31°41′18.29″N; 35°34′55.72″E. Bacteria were isolated from the soil by suspending 1 g of soil in 100 ml of sterile Luria Bertani medium (LB). Serial dilutions from the suspension were platted on LB agar medium containing concentrations of sodium chloride (NaCl) ranging from 0 to 3 M. Growth was performed at 30°C for 72 hours, and strains were selected and stored for further use. 2.2. Strain Characterization and Identification Strains were characterized by their phenotypic and biochemical characteristics according to the standard methods described in Bergey’s Manual of Systematic Bacteriology [43]. The growth at different NaCl concentrations ranging from 0 to 3 M was performed in LB medium, and the growth was maintained separately at 30°C and 37°C. Based on rRNA gene amplification and sequencing, the 16S rRNA gene was amplified using the recommended universal primers, 27F (AGAGTTTGATCCTGGCTCAG) and 1392R (GGTTACCTTGTTACGACTT), and amplification was conducted as described by Turner et al. [44]. Sanger sequencing was performed at the Center of Innovation (USMBA, Fez-Morocco) using an ABI PRISM 3130XL genetic analyzer (Applied Biosystems). Sequences were compared with 16S rRNA gene sequences available in the GenBank database. Phylogenetic relationships were established using the neighbor-joining (NJ) criteria under MEGA X software [45]. Phylogeny tests were assessed by bootstrapping with 1000 replicates, and the maximum likelihood composite was used as a substitution model. 2.3. Bacterial Culture and Crude Extract Preparation A preculture of each strain was grown to an OD600nm 0.8–1 in GYM medium (glucose 4 g/l, yeast extract 4 g/l, and malt extract 10 g/l), and 1 ml of the preculture was then used to inoculate 100 ml of GYM medium. After 48 h–72 h of incubation at 30°C under agitation (at 150 rpm), the fermentation broth was centrifuged at for 10 min, and the supernatant was filtered through a 0.22 μm nitrocellulose filter. The filtered supernatant was then brought to pH 3.0 and loaded onto a preequilibrated nonionic resin type Amberlite XAD-4-containing column. The adsorbed material was eluted with methanol as a mobile phase. Fractions were collected and dried at 40°C using a rotary evaporator. The crude dried extracts were weighed and then prepared at a concentration of 500 mg/ml in sterile distilled water for further analysis. 2.4. Determination of Phenolic Contents and Antioxidant Activities of the Crude Extracts Phenolic-containing and flavonoid-like compounds present in the crude extracts were determined using the methods described by Singleton et al. and Dewanto et al. [46, 47], and the obtained results were expressed as μg of acid gallic equivalent and μg of quercetin equivalent per mg of crude extract, respectively. The antioxidant activities of the crude extracts were assayed using 2,2-diphenyl-1-picrylhydrazyl (DPPH) scavenging activity and molybdenum Mo(VI) reducing power [48, 49]. The obtained results were expressed as μg of ascorbic acid equivalent per mg of the crude extract. The percentage of DPPH scavenging activity was calculated according to the following formula:where A0 represents the absorbance of control (DPPH solution) and A1 represents the absorbance of the experimental, respectively. 2.5. Animals In all experiments, male adult Swiss mice weighing 25 g to 30 g at the beginning of the experiments and randomly distributed throughout the study groups described below were used. Animals were maintained in constant environmental conditions (a temperature of 22 ± 1°C, 55–60% humidity, and natural light-dark cycle, with food and water ad libitum) in polyacrylic cages (6 animals/cage) containing woodchip bedding. The habitation behavior was assessed 15 days before the experiments, observing appetite, water intake, digestive transit, and neurologic signs and behavior (e.g., socialization and group behavior). Laws on animal use in biomedical research were considered in animal care and experimental procedures. 2.6. Behavioral Studies 2.6.1. General Experimental Design The present study consists of two major parts. In the first part, crude extracts were tested for their effects on modulating short-term memory and anxiety- and depression-like behaviors using Y-maze, elevated plus maze, and forced swimming test, respectively (Figure 1). To do so, two doses of the crude extracts were prepared (60/kg and 120 mg/kg) in sterile distilled water and administered orally to a group of 30 mice divided into 5 groups of 6 mice (Table 1). Animals (n = 30) were fed and allowed to drink water at a specific time (7:00 p.m.) each day during the entire administration period (7 days). Each mouse was orally administered 80 μl of the corresponding tested crude extract (SL22 and BM20) once a day for 7 days. The “control” group was kept in the exact same conditions and administered by the same volume of physiological water. Behavioral experiments began the following day after treatment. All behavioral assessments were carried out between 9:00 a.m. and 3:00 p.m.
... Thus, there is a growing interest in the use of plant extract to improve leaning, memory and general cognitive function, with a large number of reviews highlighting the benefits of some phytochemicals as brain function modulators [14,15]. Moreover, in one of our previous studies, we reported the in vitro antioxidant effects of Emilia coccinae, which could have been correlated also with some facilitating effects of the same extract on an animal model of anxiety and depression [16]. In that study, the standardized methanolic extract of Emilia coccinae significantly increased the number of open arm entries and time spent in the open arms of the elevated plus maze test and was as effective as Imipramine in inducing shortening of immobility time in forced swimming test. ...
... Behavioral testing was done on days 8 and day 14 following extract administration, 30 min after scopolamine injection. The aforementioned dosage and the duration of treatment were selected following a screening studies and previously published reports regarding Emilia coccinae biological effects [16] (see Table 1). ...
... It is somehow difficult to evaluate the motor activity of the extract with some variety of locomotory manifestations. In our previous experiment using the same extract at the same doses [16], the motor activity (number of lines crossed) in the open field was decreased with an increase of the time spent at the center of the maze as compared to control. At the same time on the EPM platform, locomotor index-number of entrance in the closed arms decreased in the extract, as compared to control. ...
... Different parts of EChave been used for the treatment of fever, epilepsy, seizures in children (Agoha et al., 1981), sore, sinusitis, ulcer, ringworm, jaundice, hernia, syphilis (Burkill, 1985), measles and cough (Edeoga et al., 2005). Some of these claims have been evaluated pharmacologically, they include antioxidant, anti-inflammatory, antidiarrheal (Okei et al., 2009), antibacterial (Ogbebor et al., 2005, antifungi (Edeoga et al., 2005), anti-ovulatory and estrogenic properties (Elvis-Of ah et al., 2016), antidiabetic and antidepressant activities (Foyet et al., 2014).These effects are due to the presence of phytochemicals in ECwhich include flavonoid, phenolic compounds (Okei et al., 2009), alkaloids, terpenoids, tannins and steroids . ...
... Different parts of EChave been used for the treatment of fever, epilepsy, seizures in children (Agoha et al., 1981), sore, sinusitis, ulcer, ringworm, jaundice, hernia, syphilis (Burkill, 1985), measles and cough (Edeoga et al., 2005). Some of these claims have been evaluated pharmacologically, they include antioxidant, anti-inflammatory, antidiarrheal (Okei et al., 2009), antibacterial (Ogbebor et al., 2005, antifungi (Edeoga et al., 2005), anti-ovulatory and estrogenic properties (Elvis-Of ah et al., 2016), antidiabetic and antidepressant activities (Foyet et al., 2014).These effects are due to the presence of phytochemicals in ECwhich include flavonoid, phenolic compounds (Okei et al., 2009), alkaloids, terpenoids, tannins and steroids . ...
... Several research works have been executed to study the phytochemical components of Emilia coccinea and also on the antimicrobial activity of the plant (Kamboj and Sulaj 2011). The pharmacological properties such as antioxidant, antidiarrheal, antimicrobial, and neuroprotective activities have been reported ( Teke et al., 2002, Zhang et al., 2013and Foyet et al., 2014. Shetonde et al., (2015) isolated a total of 24 compounds from the leaf extracts (19 and 7 compounds from the Hexane and DCM extracts, respectively; 2 being common to the two extracts. ...
Article
Background Presently, only four drugs have been approved by FDA for Alzheimer’s disease (AD). A drug repurposing approach can be fruitful in searching for promising candidates for AD. Objective The objective of the work was to evaluate the neuroprotective effect of levetiracetam (LEV) in combination with berberine (BER) in scopolamine-induced cognitive impairment in mice by applying a drug repositioning approach owing to their antioxidant potential. Methods Cognitive impairment was induced in mice by scopolamine. Morris water maze, elevated plus maze, and Y-maze were used to evaluate behavioral parameters. Assays for acetylcholinesterase (AChE), reduced glutathione (GSH), malondialdehyde (MDA), catalase, nitrite, TNF-α, and brain histopathology were performed. Results The transfer latency time and percentage of spontaneous alternation were significantly reduced and significant alterations in AChE and MDA levels, GSH concentration, and improvement in nitrite and catalase levels were also evidenced after the treatment of mice with a combination of LEV and BER in comparison to independent drugs, standard and disease control groups. The antioxidant defense was also improved and TNF-α levels were significantly reduced by a combination of LEV and BER. Improvement in neuronal damage by restoration of the cytoarchitecture of the brain was also seen in the histopathological study of the brain of treatment groups. Conclusion The present study has demonstrated that the combination of LEV and BER has significantly improved cognition in mice by lipid peroxidation inhibition, augmentation of endogenous antioxidant enzymes, the decline in TNF- α levels, and AChE activity in the brain when compared to individual drugs, standard and disease control owing to their strong antioxidant and anti-inflammatory potentials.
Article
The present work describes the neuroprotective efficacy of DHAc under escalated oxidative stress condition in scopolamine-induced amnesic mice. During the toxicity test of DHAc in mice, the acute dose (LD50) is found to be 3.468 mg/kg bw and the sub-acute dose is 0.68 mg/kg bw. Improved cognitive and learning abilities are observed in Morris water maze and Y-maze test in 10 days DHAc (0.68 mg/kg bw) treated scopolamine-induced male Swiss albino mice. In the molecular level these changes are monitored as reduced oxidative load followed by significantly lower lipid peroxidation and protein carbonylation, increased superoxide dismutase, catalase, acetylcholinesterase, caspase-3 activity and glutathione content followed by higher expression of anti apoptotic protein bcl-2 in mice brain as compared to scopolamine (1 mg/kg bw) treated mice. Meanwhile real time PCR shows higher expression of brain derived neurotrophic factor (BDNF) and synaptophysin in DHAc pretreated scopolamine treated mice brain. HPLC analysis suggested its possible blood brain barrier crossing ability. Overall DHAc reversed behavioral anomalies in the scopolamine treated mice via oxidative stress quenching, enhancing antioxidative enzyme activity, enhancing BDNF and synaptophysin mRNA levels and reducing expression of apoptotic protein Bax.
Article
The objective of the present study was to evaluate the memory enhancing activity of Lawsonia inermis Linn. leaves against scopolamine induced amnesia by elevated plus maze and Y-maze test. The Powdered leaf materials were extracted with 95% ethanol. The dried extract was subjected to phytochemical analysis and free radical scavenging activity. Acute oral toxicity was performed as per OECD guidelines 425. A dose level 200 mg/kg and 400 mg/kg were selected for pharmacological screening. Swiss albino mice of male sex were divided into ten groups of six animals each. Five groups were subjected to evaluation by elevated plus maze and remaining by Y-maze model. Immediately after evaluation, the whole brain of each animal was subjected to determination of acetyl cholinesterase (AChE), malondialdehyde (MDA), glutathione (GSH), catalase (CAT) and superoxide dismutase (SOD) activity. Extract at dose levels of 200 mg/kg and 400 mg/kg showed a significant increase in inflexion ratio in elevated plus maze and increase in percentage alternation in Y-maze model compared to negative control animals in respective models. A significant decrease in brain AChE and MDA with a significant increase in GSH, CAT and SOD levels were noted in animals treated with extract in both models. The preliminary analysis of extract showed the presence of phenolics, tannins, flavonoids and a potent invitro free radical scavenging activity. These findings suggest that, the memory enhancing effect of Lawsonia inermis leaves might be due to enhancement of cholinergic neurotransmission through inhibition of AChE activity and by stabilizing the antioxidant system.
Article
Full-text available
Neurodegenerative diseases and psychiatric disorders are one of the most important pathologies that lead to increased morbidity in populations. Both mood and anxiety disorders include mental disorders not caused by detectable organic abnormalities of the brain. At the molecular level, affective spectrum symptomatology is due to neurotransmitter dysregulation including receptor or transporter impairments and also due to faulty intracellular signaling that generally leads to impaired neurotransmission. Also, recent studies have shown the relationship between oxidative stress and the development of affective disorders. Since classical medication can cause major side effects and alternative approaches tend to be more and more trusted, it seems that plant extracts-based complementary therapies may offer superior yielding and safety compared to traditional medication.
Article
Full-text available
An assessment of the antimicrobial properties of extracts from the stem of Chasmantera dependens, the leaves of Emilia coccinea and the whole plant of Cuscuta australis plants which are used in the management of eye diseases in Nigeria is presented. The 50% methanol extracts were extracted sequentially with hexane, ethyl acetate and butanol to give fractions of various polarities which were tested for antimicrobial properties against various microorganisms including fungal yeast, Gram-positive and Gram-negative bacteria, namely Candida albicans, Bacillus subtillis, Citrobacter sp., Enterococcus faecalis, Escherichia coli, Escherichia coli ATCC 25922, Klebsiella pneumoniae, Proteus mirabilis, Pseudomonas aeruginosa, Salmonella sp., Salmonella typhimurium, Serratia marcescens, Shigella flexnerii, Staphylococcus albus,Staphylococcus aureus and Staphylococcus aureus ATCC 2593. The hexane fractions of all the plants were not found to possess antimicrobial activity on any of the microorganisms tested. The ethyl acetate fractions of C. dependens and E. coccinea were found to possess significant antimicrobial activity against several of the microorganisms while that of C. australis was active against only three of the microorganisms. The butanol fraction of E. coccinea showed significant antimicrobial activity against several of the microorganisms while those of C. dependensand C. australis were respectively active against only two and three of the microorganisms. The results support the use of E. coccinea as a potent anti-diarrhoeal agent and the uses of the plants as antimicrobials in herbal medicine.
Article
Full-text available
In this study, the influence of acute administration of ethyl acetate, ethanol and aqueous seed extracts of Z. mauritiana on spatial recognition memory in Wistar rats were investigated using the Y-maze. Spatial memory was measured by the total number of entries and duration spent in each arm of the Y-maze following administration of the extracts intraperitoneally (i.p.). Transfer latency (TL) in the Y-maze was expressed as inflexion ratio (IR). The number of arm visits during the first trial and second trial period were measured as an index of locomotor activity. Scopolamine (0.4 mg/kg) was used to induce amnesia in the animals. The results indicated that, after 24 h, IR was slightly increased (P>0.05) by ethanol and aqueous extracts while ethyl acetate extract significantly reduced the IR (P< 0.05) compared to controls. All doses of ethyl acetate extract impaired spatial recognition memory after a 24 h interval–trial interval, whereas aqueous and ethanol extracts did not showed this impairment. All the extracts significantly decreased locomotor activity of the animals (P<0.001). None of the extracts reversed scopolamine induced amnesia in the rats. These data suggests that seed extracts of Z. mauritiana impaired spatial recognition memory and decreased locomotor activity of rodents, the activity of which was greatly produced by the portion extracted by ethyl acetate.
Article
A single solution reagent is described for the determination of phosphorus in sea water. It consists of an acidified solution of ammonium molybdate containing ascorbic acid and a small amount of antimony. This reagent reacts rapidly with phosphate ion yielding a blue-purple compound which contains antimony and phosphorus in a 1:1 atomic ratio. The complex is very stable and obeys Beer's law up to a phosphate concentration of at least 2 μg/ml.The sensitivity of the procedure is comparable with that of the stannous chloride method. The salt error is less than 1 %.
Article
A microwave-assisted enzymatic extraction (MAEE) method was developed and optimized to enhance the polyphenols extraction yield from waste peanut shells. The optimum conditions were as follows: irradiation time 2.6 min, amount of cellulase 0.81 wt.%, a pH of 5.5, and incubation at 66 °C for 2.0 h. Under these conditions, the extraction yield of total polyphenols could reach 1.75 ± 0.06%, which was higher than other extraction methods including heat-refluxing extraction, ultrasonic-assisted extraction and enzyme-assisted extraction. The structural changes of the plant material after different extractions observed by scanning electron microscopy provided visual evidence of the disruption effect. Moreover, the crude extract was then purified by NKA-9 resin, the polyphenols content in the purified extract increased to 62.73%. The antioxidant activities of the crude and purified polyphenols extract were evaluated by DPPH and hydroxyl radicals, reducing power and β-carotene bleaching test. The antibacterial activities of purified extract were also tested using Oxford cup method. The results indicated that the MAEE method was efficient and environment-friendly, and the polyphenols have significant antioxidant and antibacterial activities, which can be used as a source of potential antioxidant and preservative.
Article
Alkaloids, tannins, saponins, steroid, terpenoid, flavonoids, phlobatannin and cardic glycoside distribution in ten medicinal plants belonging to different families were assessed and compared. The medicinal plants investigated were Cleome nutidosperma, Emilia coccinea, Euphorbia heterophylla, Physalis angulata, Richardia bransitensis, Scopania dulcis, Sida acuta, Spigelia anthelmia, Stachytarpheta cayennensis and Tridax procumbens. All the plants were found to contain alkaloids, tannins and flavonoids except for the absence of tannins in S. acuta and flavonoids in S. cayennsis respectively. The significance of the plants in traditional medicine and the importance of the distribution of these chemical constituents were discussed with respect to the role of these plants in ethnomedicine in Nigeria.
Article
The aim of present research is to study the temporal structure of the behavior in two strains of rats with different basal level of emotionality. To this purpose, the temporal profile of the behavior in Wistar rat and in the spontaneously more anxious DA/Han strain was analyzed in the Elevated Plus Maze. Both quantitative and multivariate t-pattern analyses were carried out. In comparison with Wistar, DA/Han subjects showed a significant reduction of the permanence in open arm and a significant increase of the time spent in the central platform of the maze. Mean frequencies of each behavioral element showed significant modifications both in open and in closed arm. Multivariate t-pattern analyses demonstrated a very different temporal profile of behavior in the two strains: Wistar rats presented 197 t-patterns of different composition, whereas DA/Han rats only 26; as to the mean number of t-patterns, Wistar presented a value of 698.90, whereas DA/Han only 92.80. Similar clear-cut differences were detected for the mean number of t-patterns in the two arms and for the time course of such t-patterns. Present study has evidenced that the temporal organization of the bahavior in Elevated Plus Maze is differently structured in two strains of rats with different basal level of emotionality.
Article
Interest in alternative medicine and plant-derived medications that affect the "mind" is growing rapidly since last two decades. The aim of the present study was to investigate the effects of ethanolic extract of flower of Plumeria rubra (PR) along with its fractions in the elevated plus-maze (EPM) model of anxiety. The P. rubra extract or its fractions was administered orally to male Swiss mice, at graded doses, 1h prior to behavioural assessment. The PR extract at the dose of 100mg/kg p.o., significantly increased the time spent in the open arms of the EPM. Further, the anxiolytic properties of hexane, chloroform and butanolic soluble and insoluble fractions at one-fifth of the original dose were also observed in the EPM task. Out of which butanol insoluble fraction showed significant anxiolytic activity comparable to standard anxiolytic drug, diazepam. Further, pretreatment with crude ethanolic extract and butane insoluble fraction showed no significant effects in the horizontal activity, total distance travelled and stereotypy count in the animal activity monitor and had no motor in-coordination side effects in the rotarod test in mice. These observations suggest that the flower extract of P. rubra and its insoluble butanolic fraction might possess significant anxiolytic potential to be pursued further for drug development process.
Article
Objective: To explore the protective effects of the Chinese Yi-Qi-Bu-Shen recipe (YB) against neuronal injury induced by hypoxia-reoxygenation, which has shown beneficial effect in improving the brain function of type 2 diabetics likely through its antihyperglycemic, antioxidant activity, and investigate its mechanisms. Methods: The bilateral hippocampus was collected from newborn rats to establish single cell suspension. On the 10th day, the primarily cultured hippocampal neurons were randomly divided into five groups: the normal group (NG), the hypoxia/reoxygenation group (HG), and groups protected with small, medium and large dosages of YB (SG, MG and LG, respectively). The YB-protected groups were treated with different concentrations of YB containing serum before reoxygenation. The metabolic rate of MTT, the malondialdehyde (MDA) content, and the activity of superoxide dismutase (SOD) and lactate dehydrogenase (LDH) were measured with assay kits. The apoptosis rate of hippocampal neurons were tested using flow cytometry analysis. RT-PCR was used to evaluate the mRNA expressions of bcl-2 and bax genes. Results: The SOD activity, the cell survival rate, the bcl-2/bax ratio, and the bcl-2mRNA expression in the HG group were significantly lower (all P<0.01), but the levels of MDA and LDH, the apoptosis rate, and the bax mRNA expression were higher (all P<0.01) than those in the NG group. The SOD activity, the cell survival, the bcl-2mRNA expression, and the bcl-2/bax ratio were significantly higher in all of the YB-protected groups (all P<0.01), but the level of MDA and LDH, the apoptosis rate, and the bax mRNA expression were lower (P<0.01, P<0.05) than those in the HG group in a dose dependent manner. Conclusion: The YB extract has a protective effect on hippocampal neurons against injury induced by hypoxia/reoxygenation, through its antioxidant activity and the regulation of apoptosis.